Long term continuous oxygen therapy for at least 15 hours a day has been shown to prolong life in patients with severe hypoxaemia due to chronic airflow limitation.'2 It may also be of symptomatic benefit in patients with chronic hypoxaemia due to other lung diseases.' Oxygen improves performance and reduces dyspnoea during exercise4 and improves measures of psychological function.5
Most patients receiving continuous domiciliary oxygen in England use oxygen concentrators with nasal cannulas. With this system oxygen is wasted to the atmosphere and oxygen delivery is limited by the maximum flow rates produced by concentrators. Portable oxygen can be provided in the form of compressed gas, but cylinders may last for only two hours with nasal cannulas before they need to be refilled, limiting the length of time that patients can be away from their concentrator. Some patients find nasal cannulas uncomfortable or cosmetically embarassing and this may adversely influence compliance.
Transtracheal oxygen delivery avoids many of these problems. Oxygen is delivered initially at 025 1/min through the transtracheal catheter and the patient is observed in hospital overnight for any evidence of surgical emphysema. The flow rate is then increased to that required to maintain a resting Pao2 of at least 8 kPa. This is usually half the flow rate required with nasal cannulas. 0 An experimental catheter was used for a short period in two patients but was found to be unsatisfactory (see below).
Baseline lung function, packed cell volume, and arterial blood gas tensions were recorded routinely when the patients were in a stable condition before they were accepted into the transtracheal programme. though one (associated with a partial catheter fracture) occurred at seven days. Surgical emphysema did not impair ventilation and it resolved in all instances after disconnection of the oxygen source from the transtracheal catheter. Two episodes followed a change of catheter with a previously established tract. One case followed replacement of a catheter by the patient after accidental dislodgement at home. Two of the completely fractured catheters required bronchoscopy for their removal (one fibreoptic, one rigid), but there were no serious sequelae. Infections occurred on 34 occasions but were usually minor and rapidly responded to oral antibiotics. In most culture positive episodes of infection the organism was Staphylococcus aureus. Two patients had colonisation of sputum with Pseudomonas sp, associated with repeatedly positive catheter tip cultures with the same organism. Two patients had persistent local infection with methicillin resistant Staphylococcus aureus and had to return to oxygen therapy via nasal cannulas.
Minor (streak) haemoptysis occurred occasionally in the first few days after a change or insertion of catheter. Two patients had more persistent haemoptysis and underwent fibreoptic bronchoscopy. No malignant lesions were found. Both had small areas of-abrasion on the posterior tracheal wall adjacent to the catheter tip.
Increased cough shortly after transtracheal catheter insertion usually settled spontaneously, but in one case was associated with cephaloversion of the catheter. One patient using a catheter of experimental design had a brief but frightening episode of respiratory distress that resolved after he managed to expectorate a sputum plug, which we believe might have accumulated on the catheter tip.
Ten patients (27%) are known to have discontinued transtracheal oxygen therapy before death, five within the first six weeks (table 3) . One patient had been accepted on the waiting list for heart-lung transplantation and the transtracheal catheter was removed to eliminate a possible source of infection. Two patients elected not to continue with transtracheal 
